Preoperative chemotherapy for resectable thoracic esophageal cancer

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 5, 2015, Pages

  Kidane, Biniam ^a   Coughlin, Shaun ^a   Vogt, Kelly ^a   Malthaner, Richard ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; VINBLASTINE; VINDESINE;

ANASTOMOSIS LEAKAGE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; DRUG EFFICACY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GASTROINTESTINAL DISEASE; HAZARD RATIO; HUMAN; INFECTIOUS COMPLICATION; LOCAL RECURRENCE FREE SURVIVAL; LUNG COMPLICATION; META ANALYSIS; MORBIDITY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE CHEMOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESECTABLE THORACIC ESOPHAGEAL CANCER; REVIEW; SENSITIVITY ANALYSIS; SURGICAL MORTALITY; SYSTEMATIC REVIEW; ESOPHAGEAL NEOPLASMS; LIFE EXPECTANCY; MORTALITY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE CARE; PROCEDURES; QUALITY OF LIFE; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; LIFE EXPECTANCY; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84945400596     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001556.pub3     Document Type: Review

References (62)

1. Ancona E, Ruol A, Chiarion-Sileni V, Santi S, Baldan N, Buin F, et al. Prospective randomized trial of preoperative chemotherapy versus surgery alone in operable squamous cell carcinoma of the esophagus. Preliminary report on response to chemotherapy, pre- and postoperative morbidity and mortality [Studio prospettico randomizzato di chemioterapia neoadiuvante versus sola chirurgia nel cancro operabile (T2-3, ogni N, M0) dell'esofago. Valutazione della risposta alla chemioterapia e della morbilita e mortalita pre e postoperatorie]. Acta Chirurgica Italica 1995;51(4):308-17. [: 95277909]
2. Ancona E, Ruol A, Santi S, Chiarion V, Merigliano S, Petrin GF, et al. Prognostic role of downstaging after neoadjuvant chemotherapy in potentially resectable (T2-3 Nx M0) esophageal squamous cell carcinoma. Canadian Journal of Gastroenterology 1998;12(Suppl B):82.
3. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001;91(11):2165-74. [MEDLINE: 1802; PUBMED: 11391598]
4. Baba M, Natsugoe S, Shimada M, Nakano S, Kusano C, Fukumoto T, et al. Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus. Diseases of the Esophagus 2000;13(2):136-41. [: 2000408961; PUBMED: 14601905]
5. Baba M, Natsugoe S, Shimada M, Nakano S, Shirao K, Kusano C, et al. Does preoperative chemotherapy cause adverse effects on the perioperative course of patients undergoing esophagectomy for carcinoma?. Japanese Journal of Thoracic and Cardiovascular Surgery 1999;47(5):199-203. [MEDLINE: 99331177]
6. Boonstra JJ, Kok TC, Wijnhoven PL, van Heijl M, van Berge Henegouwen MI, Ten Kate FJW, et al. Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Longterm results of a randomized controlled trial. BMC Cancer 2011;11:181. [DOI: 10.1186/1471-2407-11-181; PUBMED: 21595951]
7. Kok TC, van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1997;17:A984. [: 98642984]
8. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. New England Journal of Medicine 1998;339(27):1979-84. [PUBMED: 9869669]
9. Kelsen DP, Winter KA, Gunderson LI, Mortimer J, Estes NC, Haller DG, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer [Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer]. Journal of Clinical Oncology 2007;25:3719-25.
10. Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. Journal of Thoracic and Cardiovascular Surgery 1997;114(2):210-7. [MEDLINE: 1806; PUBMED: 9270638]
11. Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaang S, et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. Journal of Surgical Oncology 1994;56(3):191-7. [MEDLINE: 649; PUBMED: 7518020]
12. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without pre-operative chemotherapy in esophageal cancer. Journal of Clinical Oncology 2009;27(30):5062-7. [DOI: 10.1200/JCO.2009.22.2083; MEDLINE: 22045677;: 12049861; PUBMED: 19770374]
13. Clark PI. Medical Research Council randomised phase III trial of surgery with or without pre-operative chemotherapy in resectable cancer of the oesophagus. British Journal of Cancer 2000;83 (Supplement 1):1, Y.
14. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
15. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World Journal of Surgery 1992;16(6):1104-9. [MEDLINE: 1050; PUBMED: 1455880]
16. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. Journal of Thoracic Cardiovascular Surgery 1988;96(2):242-8. [MEDLINE: 716; PUBMED: 2456424]
17. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Archives of Surgery 1992;127(12):1446-50. [MEDLINE: 1049; PUBMED: 1365692]
18. Stilidi I, Bokhyan V, Tryakin A, Suleymanov E, Kononets P, Malikhova O, et al. Preoperative chemotherapy followed by resection vs. surgery alone for locally advanced esophageal carcinoma: interim analysis of a randomized study. Journal of Clinical Oncology 2006;24(18S):4055.
19. Wang C, Ding T, Chang L. A randomized clinical study of preoperative chemotherapy for esophageal carcinoma. Zhonghua Zhong Liu Za Zhi 2001;23(3):254-5. [MEDLINE: 1804; PUBMED: 11783101]
20. Wang ZY. Preoperative chemotherapy for esophageal cancer. Chung-Hua-Chung-Liu-Tsa-Chih 1986;8(1):61-63. [MEDLINE: 86273958]
21. Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. Journal of Clinical Oncology 2011;29(13):1715-21. [PUBMED: 21444866]
22. Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB. Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies. Annals of Oncology 1996;7(4):355-9.
23. Boige V, Pignon J, Saint-Aubert B, Lasser P, Conroy T, Bouche O, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of the stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. Journal of Clinical Oncology 2007;25(18S):4510.
24. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicoldon M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. The New England Journal of Medicine 2006;355(1):11-20.
25. Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. Journal of Clinical Oncology 2010;28:5210-8.
26. Fietkau R. No improvement of prognosis by neoadjuvant chemotherapy alone in operable esophageal carcinoma [Keine Verbesserung der Prognose des operablen Osophaguskarzinoms durch eine alleinige neoadjuvante Chemotherapie]. Strahlentherapie und Onkologie 1999;175(5):251-2. [: 99285106]
27. Hohenberger W. Surgical resection with or without preoperative chemotherapy in esophageal cancer: a randomized controlled trial [German]. Strahlentherapie und Onkologie 2003;179(4):271-2. [MEDLINE: 1825]
28. Roth JA. Squamous cell cancer of the esophagus. Treatment concept at the Houston M.D. Anderson Cancer Center. Chirurg 1992;63(9):683-8. [MEDLINE: 93010028]
29. Schlag P. Randomized study of preoperative chemotherapy in squamous cell cancer of the esophagus. CAO Esophageal Cancer Study Group. Chirurg 1992;63(9):709-14. [MEDLINE: 93010032]
30. Thirion PG, Michiels S, Le Maitre A, Tierney J. Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma. Journal of Clinical Oncology 2007;45(18S):4512.
31. Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. American Journal of Surgery 2002;183(3):274-9. [MEDLINE: 1803]
32. Ancona E, Ruol A, Chiarion-Sileni V, Santi S, Baldan N, Buin F, et al. Prospective randomized trial of preoperative chemotherapy versus surgery alone in operable squamous cell carcinoma of the esophagus. Preliminary report on response to chemotherapy, pre- and postoperative morbidity and mortality [Studio prospettico randomizzato di chemioterapia neoadiuvante versus sola chirurgia nel cancro operabile (T2-3, ogni N, M0) dell'esofago. Valutazione della risposta alla chemioterapia e della morbilita e mortalita pre e postoperatorie]. Acta Chirurgica Italica 1995;51(4):308-17. [: 95277909]
33. Ancona E, Ruol A, Santi S, Chiarion V, Merigliano S, Petrin GF, et al. Prognostic role of downstaging after neoadjuvant chemotherapy in potentially resectable (T2-3 Nx M0) esophageal squamous cell carcinoma. Canadian Journal of Gastroenterology 1998;12(Suppl B):82.
34. Baba M, Natsugoe S, Shimada M, Nakano S, Shirao K, Kusano C, et al. Does preoperative chemotherapy cause adverse effects on the perioperative course of patients undergoing esophagectomy for carcinoma?. Japanese Journal of Thoracic and Cardiovascular Surgery 1999;47(5):199-203. [MEDLINE: 99331177]
35. Blot WJ, Devesa SS, Kneller RW. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
36. Bosset JF, Mercier M, Triboulet JP, Conroy T, Seitz JF. Surgical resection with and without chemotherapy in oesophageal cancer. Lancet 2002;360(9340):1173-4. [MEDLINE: 1808]
37. Cancer Care Ontario. Incidence and mortality in Ontario, 2009. Internet Communication. https://www.cancercare.on.ca/ocs/csurv/stats/ontario/ (accessed 24 April 2015).
38. Clark PI. Medical Research Council randomised phase III trial of surgery with or without pre-operative chemotherapy in resectable cancer of the oesophagus. British Journal of Cancer 2000;83 (Supplement 1):1, Y.
39. DeMeester TR, Barlow AP. Surgery and current management for cancer of the esophagus. Current Problems in Surgery 1988;25:535-605.
40. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88. [MEDLINE: 840]
41. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta analysis. Lancet Oncology 2007;8:226-34.
42. Goldie JH, Coldman AJ. The genetic origin of drug resistance in neoplasms: implication for systemic therapy. Cancer Research 1984;44:3643.
43. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
44. Jadad AR. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
45. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Annals of Surgical Oncology 2003;10(7):754-61.
46. Kelsen DP, Winter KA, Gunderson LI, Mortimer J, Estes NC, Haller DG, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer [Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer]. Journal of Clinical Oncology 2007;25:3719-25.
47. Kok TC, van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1997;17:A984. [: 98642984]
48. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33. [MEDLINE: 880]
49. Law SY, Fok M, Cheng SW, Wong J. A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia. Surgery Gynecology & Obstetrics 1992;175(2):107-12.
50. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy [see comments]. Annals of Surgery 1992;216(5):583-90.
51. Lerut T. Esophageal surgery at the end of the millennium. Journal of Thoracic and Cardiovascular Surgery 1998;116(1):1-20.
52. Lieberman MD, Shriver CD, Bleckner S, Burt M. Carcinoma of the esophagus. Prognostic significance of histologic type. Journal of Thoracic and Cardiovascular Surgery 1995;109(1):130-8.
53. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: Aa randomised controlled trial. Lancet 2002;359:1727-33.
54. Orringer MB. Multimodality therapy for esophageal carcinoma - update. Chest 1993;103:406S-9S.
55. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
56. Petitti DB. In: Kelsey JL, Marmot MG, Stolley PD, Vessey MP editor(s). Meta-analysis, Decision Analysis, and Cost-Effectiveness Analysis. 1st Edition. Vol. 24, New York: Oxford University Press, 1994.
57. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. International Journal of Cancer 1999;83(1):18-29. [: 0020-7136]
58. Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, et al. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. European Journal of Cancer 2013;49:3149-58.
59. Wang ZY. Preoperative chemotherapy for esophageal cancer. Chung-Hua-Chung-Liu-Tsa-Chih 1986;8(1):61-3. [MEDLINE: 86273958]
60. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD001556.pub2]
61. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD001556.pub2]
62. Malthaner R, Collin S, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001556.pub2]